YZILabs Management Ltd. - 17 Sep 2026 Form 4 Insider Report for CEA Industries Inc. (BNC)

Reporting relationship: 10%+ Owner
Issuer ticker: BNC
Reported as of: 17 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 Sep 2026, 16:12:40 UTC
Source filing: View source filing
Reporting owner signature: YZiLabs Management Ltd, By: /s/ Ling Zhang, Authorized Signatory

Key filing fact

YZILabs Management Ltd. filed Form 4 for CEA Industries Inc. (BNC) on 21 Sep 2026.

Key facts

This page summarizes YZILabs Management Ltd.'s Form 4 filing for CEA Industries Inc. (BNC).
4 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 21 Sep 2026, 16:12.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002098271 Primary reporting owner

YZILabs Management Ltd.

Relationship: 10%+ Owner
Address: 2ND FLOOR, WATER'S EDGE BUILDING, WICKHAMS CAY II, ROAD TOWN TORTOLA, VIRGIN ISLANDS, BRITISH
Signature: YZiLabs Management Ltd, By: /s/ Ling Zhang, Authorized Signatory
Signature date: 21 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BNC transaction

Common Stock, par value $0.00001 per share

Exercise of in-the-money or at-the-money derivative security

Transaction value
Shares: +2,180,631
Change %: +101%
Price
Shares after: 4,331,112
Date: 17 Sep 2026
Ownership: Direct
Footnotes: F1, F2, F3

BNC transaction

Common Stock, par value $0.00001 per share

Exercise of in-the-money or at-the-money derivative security

Transaction value
Shares: +5,418,633
Change %: +125%
Price
Shares after: 9,749,745
Date: 17 Sep 2026
Ownership: Direct
Footnotes: F1, F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BNC transaction Derivative

Strategic Advisor Warrants

Exercise of in-the-money or at-the-money derivative security

Transaction value
Shares: -2,180,631
Change %: -61%
Price
Shares after: 1,383,728
Date: 17 Sep 2026
Ownership: Direct
Underlying class: Common Stock, $0.00001 per share
Underlying amount: 2,180,631
Exercise price
Footnotes: F1, F2, F3, F4, F5

BNC transaction Derivative

Pre-Funded Warrants

Exercise of in-the-money or at-the-money derivative security

Transaction value
Shares: -5,418,633
Change %: -70%
Price
Shares after: 2,331,877
Date: 17 Sep 2026
Ownership: Direct
Underlying class: Common Stock, $0.00001 per share
Underlying amount: 5,418,633
Exercise price
Footnotes: F1, F2, F3, F5, F6

BNC holding Derivative

Stapled Warrants

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 9,900,991
Date: 17 Sep 2026
Ownership: Direct
Underlying class: Common Stock, $0.00001 per share
Underlying amount: 9,900,991
Exercise price: $15.15
Footnotes: F2, F3, F5, F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

The exercise price is $0.00001 per share.

Footnote F2

This Form 4 is filed jointly by YZiLabs Management Ltd, a British Virgin Islands business company ("YZi Labs") and Changpeng Zhao ("Mr. Zhao"), a citizen of the United Arab Emirates (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that owns more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Footnote F3

Securities beneficially owned by YZi Labs. As the sole director of YZi Labs, Mr. Zhao may be deemed to beneficially own the securities beneficially owned directly by YZi Labs.

Footnote F4

The Strategic Advisor Warrants are immediately exercisable at an exercise price equal to $0.00001 per share and may be exercised at any point on or prior to 5:00 p.m. on August 5, 2030, subject to the SAW Beneficial Ownership Limitation (as defined below). Pursuant to the terms of the Strategic Advisor Warrants, the holder may increase or decrease the SAW Beneficial Ownership Limitation upon 61 days' notice to the Issuer, provided that such Beneficial Ownership Limitation in no event exceeds 9.99% of the Issuer's then outstanding shares of Common Stock. As of the date hereof, the Beneficial Ownership Limitation under the Strategic Advisor Warrants is 9.99% of the Issuer's then outstanding shares of Common Stock (the "SAW Beneficial Ownership Limitation"). On September 17, YZi Labs exercised 2,180,631 Strategic Advisor Warrants, representing 2,180,631 shares of Common Stock, at an exercise price of $0.00001 per share.

Footnote F5

Each of the Pre-Funded Warrants, the Stapled Warrants and the Strategic Advisor Warrants either provide, or the holder has elected, that the holder shall not have the right to exercise any portion of any such warrants to the extent that after giving effect to such issuance after exercise, such holder and certain of its affiliates would be deemed to beneficially own, as determined in accordance with Section 13(d) of the Exchange Act, more than a certain percentage of the Issuer's then outstanding shares of common stock (the "Beneficial Ownership Limitations"), as adjusted pursuant to the terms of the Pre-Funded Warrants, the Stapled Warrants and the Strategic Advisor Warrants. On September 17, 2026, the Issuer agreed to waive the required 61 days' notice period to the Issuer with respect to an increase in the Beneficial Ownership Limitations under the terms of each of the Pre-Funded Warrants and the Strategic Advisor Warrants held by YZi Labs.

Footnote F6

The Pre-Funded Warrants are immediately exercisable at an initial exercise price equal to $0.00001 per share and may be exercised at any time until the Pre-Funded Warrants are exercised in full, subject to the PFW Beneficial Ownership Limitation (as defined below). Pursuant to the terms of the Pre-Funded Warrants, the holder may increase or decrease the PFW Beneficial Ownership Limitation upon 61 days' notice to the Issuer, provided that such Beneficial Ownership Limitation in no event exceeds 19.99% of the Issuer's then outstanding shares of Common Stock. As of the date hereof, the Beneficial Ownership Limitation under the Pre-Funded Warrants is 19.99% of the Issuer's then outstanding shares of Common Stock (the "PFW Beneficial Ownership Limitation"). On September 17, 2026, YZi Labs exercised 5,418,633 Pre-Funded Warrants, representing 5,418,633 shares of Common Stock, at an exercise price of $0.00001 per share.

Footnote F7

The Stapled Warrants are immediately exercisable at an initial exercise price equal to $15.15 per Share and may be exercised at any time on or prior to 5:00 p.m. on June 28, 2028, subject to the SW Beneficial Ownership Limitation (as defined below). Pursuant to the terms of the Stapled Warrants, the holder may increase or decrease the SW Beneficial Ownership Limitation upon 61 days' notice to the Issuer to any other percentage specified in the notice. As of the date hereof, the Beneficial Ownership Limitation under the Stapled Warrants is 4.99% of the Issuer's then outstanding shares of Common Stock (the "SW Beneficial Ownership Limitation").